Ignite Creation Date:
2024-05-06 @ 8:13 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06304350
Status:
RECRUITING
Last Update Posted:
2024-03-13
First Post:
2024-02-21
Brief Title:
Pembrolizumab Combined With Preoperative Chemotherapy Albumin PaclitaxelCarboplatin Neoadjuvant Therapy for Resectable Locally Advanced Stage IIIII Esophageal Squamous Cell Carcinoma
Sponsor:
Tongji University
Organization:
Tongji University
Organization Data
Organization:
Tongji University
Class:
OTHER
Study ID:
SGHDOT-24-20
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Tongji University
Lead Sponsor Class:
OTHER
Responsible Party:
Jiang Fan
Responsible Party Title:
Director of Department of Thoracic Surgery
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Tongji University
Old Name:
None
Old Organization:
None